571 / 1631
R2 in Indolent NHL : Long Term FU
Marginal Zone Lymphoma Small Lymphocytic Lymphoma
Follicular Lymphoma
Progression Free Survival
Overall Survival
5 Year PFS: 65%
5 Year PFS: 48%
5 Year PFS: 50%
5 Year OS: 96%
5 Year OS: 96%
5 Year OS: 93%
Fowler N, et al. ASCO 2017